Literature DB >> 25418695

Sphingosine-1-phosphate receptor 2: a novel bile acid receptor and regulator of hepatic lipid metabolism?

John Y L Chiang1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25418695      PMCID： PMC4376601          DOI： 10.1002/hep.27616

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.

Authors:  Masayuki Nagahashi; Kazuaki Takabe; Runping Liu; Kesong Peng; Xiang Wang; Yun Wang; Nitai C Hait; Xuan Wang; Jeremy C Allegood; Akimitsu Yamada; Tomoyoshi Aoyagi; Jie Liang; William M Pandak; Sarah Spiegel; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

2.  Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Authors:  Elaine Studer; Xiqiao Zhou; Renping Zhao; Yun Wang; Kazuaki Takabe; Masayuki Nagahashi; William M Pandak; Paul Dent; Sarah Spiegel; Ruihua Shi; Weiren Xu; Xuyuan Liu; Pat Bohdan; Luyong Zhang; Huiping Zhou; Phillip B Hylemon
Journal:  Hepatology       Date:  2011-11-30       Impact factor: 17.425

3.  Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.

Authors:  Sunmi Seok; Deepthi Kanamaluru; Zhen Xiao; Daniel Ryerson; Sung-E Choi; Kelly Suino-Powell; H Eric Xu; Timothy D Veenstra; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

4.  Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.

Authors:  Raffaella M Gadaleta; Karel J van Erpecum; Bas Oldenburg; Ellen C L Willemsen; Willem Renooij; Stefania Murzilli; Leo W J Klomp; Peter D Siersema; Marguerite E I Schipper; Silvio Danese; Giuseppe Penna; Gilles Laverny; Luciano Adorini; Antonio Moschetta; Saskia W C van Mil
Journal:  Gut       Date:  2011-01-17       Impact factor: 23.059

Review 5.  Sphingolipid metabolites in inflammatory disease.

Authors:  Michael Maceyka; Sarah Spiegel
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

6.  Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.

Authors:  Songwen Zhang; Juan Wang; Qiangyuan Liu; Douglas C Harnish
Journal:  J Hepatol       Date:  2009-05-18       Impact factor: 25.083

Review 7.  Bile acid signaling in metabolic disease and drug therapy.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

8.  Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

Authors:  Nitai C Hait; Jeremy Allegood; Michael Maceyka; Graham M Strub; Kuzhuvelil B Harikumar; Sandeep K Singh; Cheng Luo; Ronen Marmorstein; Tomasz Kordula; Sheldon Milstien; Sarah Spiegel
Journal:  Science       Date:  2009-09-04       Impact factor: 47.728

Review 9.  Bile acid-mediated control of liver triglycerides.

Authors:  Claudia Fuchs; Thierry Claudel; Michael Trauner
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115
  9 in total
  2 in total

Review 1.  Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Authors:  Claudia D Fuchs; Michael Trauner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

Review 2.  Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.

Authors:  Anita Kumari; Dharam Pal Pathak; Shailendra Asthana
Journal:  Int J Biol Sci       Date:  2020-06-14       Impact factor: 6.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.